Bendroflumethiazide
From Wikipedia, the free encyclopedia
Bendroflumethiazide
|
|
Systematic (IUPAC) name | |
3-benzyl-5,5-dioxo-9- (trifluoromethyl)-5λ6- thia-2,4-diazabicyclo[4.4.0]deca-7, 9,11-triene-8-sulfonamide | |
Identifiers | |
CAS number | 73-48-3 |
ATC code | C03AA01 |
PubChem | 2315 |
DrugBank | APRD00666 |
Chemical data | |
Formula | C15H14N3F3O4S2 |
Mol. weight | 421.417 g/mol |
Pharmacokinetic data | |
Bioavailability | 100% |
Protein binding | 96% |
Metabolism | extensive |
Half life | 3-4 hours[1] |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
Risk neonatal thrombocytopenia in 3rd trimester[2] |
Legal status |
POM(UK) |
Routes | oral |
Bendroflumethiazide INN (formerly BAN bendrofluazide), is a thiazide diuretic, used to treat hypertension.
[edit] Footnotes
- ^ Ed. Sean C. Sweetman Martindale: The complete drug reference, 33, Pharmaceutical Press.
- ^ BNF 45 March 2003
[edit] External links
Antihypertensives (C02) and diuretics (C03) edit | ||
---|---|---|
Antiadrenergic agents (including alpha): |
Clonidine, Doxazosin, Guanethidine, Guanfacine, Lofexidine, Mecamylamine, Methyldopa, Moxonidine, Prazosin, Rescinnamine, Reserpine |
|
Vasodilators: |
Diazoxide, Hydralazine, Minoxidil, Nitroprusside, Phentolamine |
|
Other antihypertensives: | ||
Low ceiling diuretics: |
Bendroflumethiazide, Chlorothiazide, Chlortalidone, Hydrochlorothiazide, Indapamide, Quinethazone, Mersalyl, Metolazone, Theobromine |
|
High ceiling diuretics: | ||
Potassium-sparing diuretics: |